International angiology : a journal of the International Union of AngiologyHumansMaleRivaroxabanPeripheral Arterial DiseaseFemale
Efficacy of dual therapy with Aspirin and rivaroxaban in symptomatic peripheral artery disease: the DOLOMITI experience.
Luca Ferretto, Marco Penzo, Riccardo Bozza, Francesca Ghirardini, Romeo C Martini
Published: 202510.23736/S0392-9590.25.05447-1
Abstract
BACKGROUND: Peripheral artery disease (PAD) increases cardiovascular (CV) mortality risk. Dual therapy (DT) with aspirin and rivaroxaban reduces major CV adverse events and limb ischemia. An analysis of patients at high CV risk undergoing DT was cond…
Preview only. Read the full abstract at the source